TETAPUR
TETAPUR
Not authorised
- Clostridium tetani, toxoid
Product identification
Medicine name:
TETAPUR
Active substance:
- Clostridium tetani, toxoid
Target species:
-
Cattle
-
Pig
-
Sheep
-
Equid
-
Dog
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Clostridium tetani, toxoid
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Pig
-
Sheep
-
Equid
-
Dog
-
-
Subcutaneous use
-
Cattle
-
Sheep
-
Pig
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AB
- QI04AB
- QI05AB
- QI07AB
- QI09AB
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/1318229 8/1981
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 24/03/2022
How useful was this page?:
